RCUS - Exelixis slips as Barclays downgrades on lack of catalysts April, 11 2024 10:10 AM Arcus Biosciences Inc. 2024-04-11 10:10:03 ET More on Exelixis Exelixis: Patent Woes And Challenging Market Dynamics Make For A Testy 2024 Exelixis, Inc. (EXEL) Q4 2023 Earnings Call Transcript Exelixis: 2024 Looking Good In The Mid-Term Exelixis Q4 2023 Earnings Preview Seeking Alpha’s Quant Rating on Exelixis For further details see: Exelixis slips as Barclays downgrades on lack of catalysts